Just found this figure from 2009 announcement. Interesting, current MC is only $22 million.
Let bygones to be bygones, but after FAD meeting, EMA meeting, the simplified trial III should add more value to 2009 figure.
"there is clear evidence that ATC would have significant patient support, with independent analysis suggesting that the per annum sales market for ATC could be between $100M and $400M." 04, 2012
Based on sales revenue $100M--$400M, I think the valuation figure in 2009 is still conservative.
What on earth for the "clear evidence" ?
Add to My Watchlist
What is My Watchlist?